Evidence map›Paper›PMID 19060121›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2009

Cardiovascular responses to microinjections of urocortin 3 into the nucleus tractus solitarius of the rat.

Takeshi Nakamura, Kazumi Kawabe, Hreday N Sapru

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Hypoxia activates a neuropeptidergic pathway from the paraventricular nucleus of the hypothalamus to the nucleus tractus solitarii.American journal of physiology. Regulatory, integrative and comparative physiology · 2018
    Article
  2. Article
  3. Article
  4. Article
  5. Mechanisms of cardiovascular actions of urocortins in the hypothalamic arcuate nucleus of the rat.American journal of physiology. Heart and circulatory physiology · 2013
    Article
  6. Article
  7. Bradycardic effects of microinjections of urocortin 3 into the nucleus ambiguus of the rat.American journal of physiology. Regulatory, integrative and comparative physiology · 2012
    Article
  8. Article
  9. Article
  10. Microinjections of urocortin1 into the nucleus ambiguus of the rat elicit bradycardia.American journal of physiology. Heart and circulatory physiology · 2011
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Takeshi NakamuraDepartment of Neurological Surgery, UMDNJ-New Jersey Medical School, Newark, NJ, USA.
Kazumi Kawabe
Hreday N Sapru
Rutgers, The State University of New Jersey · US

Funding

Central Cardiovascular Regulation: Role of Urocortin IIIR01HL024347 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SAPRU, HREDAY N. · 1985 to 2012
$4.0M
Central Cardiovascular Regulation and Proangiotensin-12R01HL076248 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SAPRU, HREDAY N. · 2004 to 2013
$3.3M
NHLBI NIH HHS HL-024347NHLBI NIH HHS HL-076248
6 · The paper itself

Abstract

Urocortin 3 (Ucn3) is a new member of the corticotropin-releasing factor (CRF) peptide family and is considered to be a specific and endogenous ligand for CRF type 2 receptors (CRF2Rs). The presence of CRF(2)Rs has been reported in the nucleus tractus solitarius (NTS) of the rat. It was hypothesized that the activation of CRF2Rs in the medial NTS (mNTS) may play a role in cardiovascular regulation. This hypothesis was tested in urethane-anesthetized, artificially ventilated, adult male Wistar rats. Microinjections (100 nl) of Ucn3 (0.03, 0.06, 0.12, and 0.25 mM) into the mNTS of anesthetized rats elicited decreases in mean arterial pressure (MAP: 5.0 +/- 1.0, 21.6 +/- 2.6, 20.0 +/- 2.8, and 12.7 +/- 3.4 mmHg, respectively) and heart rate (HR: 7.8 +/- 2.6, 46.2 +/- 9.3, 34.5 +/- 8.4, and 16.6 +/- 4.9 beats/min, respectively). Microinjections of artificial cerebrospinal fluid (100 nl) into the mNTS did not elicit cardiovascular responses. Maximum decreases in MAP and HR were elicited by 0.06 mM concentration of Ucn3. Cardiovascular responses to Ucn3 were similar in unanesthetized midcollicular decerebrate rats. A bilateral vagotomy completely abolished Ucn3-induced bradycardia. The decreases in MAP and HR elicited by Ucn3 (0.06 mM) were completely blocked by astressin (1 mM; nonselective CRFR antagonist) and K41498 (5 mM; selective CRF2R antagonist). Microinjections of Ucn3 (0.06 mM) into the mNTS decreased the efferent greater splanchnic nerve activity. After the blockade of CRF2Rs in the mNTS, a Ucn3-induced decrease in the efferent sympathetic nerve discharge was abolished. These results indicate that Ucn3 microinjections into the mNTS exerted excitatory effects on the mNTS neurons via CRF2Rs, leading to depressor and bradycardic responses.

Indexed as

Blood PressureHeart RateAmphibian ProteinsAnesthesia, GeneralAnimalsBradycardiaCorticotropin-Releasing HormoneDecerebrate StateDose-Response Relationship, DrugHeartHypotensionMaleMicroinjectionsPeptide FragmentsPeptide HormonesRatsAmphibian ProteinsastressinCorticotropin-Releasing HormoneCRF receptor type 2Peptide FragmentsPeptide HormonesReceptors, Corticotropin-Releasing HormonesauvagineUrocortins

Identifiers

PMID19060121
PMCPMC2643898
OpenAlexW2026647675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.